Febuxostat 80mg Tablets Furic

Trade Name: Furic

Manufacturer: Lupin Ltd

Presentation: Tablet

Strength: 80mg


What is the purpose of Febuxostat 80mg Tablets Furic?

Febuxostat 80mg Tablets Furic is a gout treatment medication (a condition that causes pain, swelling, and stiffness in the joints due to the accumulation of uric acid crystals). It works by lowering uric acid production in the body, avoiding the formation of urate crystals in the joints.

What is the purpose of Furic?

Febuxostat is used to treat hyperuricemia (excess uric acid in the blood) in gout patients who have failed to respond to allopurinol or who are unable to take allopurinol. This medication inhibits the enzyme xanthine oxidase. It works by causing the body to create less uric acid.

When should you start taking febuxostat?

Take it early thing in the morning if possible. Talk to your doctor, nurse, or pharmacist if you work shifts or want to take your medicine at nightFebuxostat is a medication that can be taken with or without food. To avoid gout attacks, take febuxostat every day.

What is the best time to discontinue taking Febuxostat 80mg Tablets Furic?

Important: Febuxostat 80mg Tablets Furic has been linked to a significant allergic reaction in a few cases (such as swelling around the face, difficulty breathing, swollen glands, and skin rash). Although these symptoms are uncommon, you should stop taking Febuxostat and notify your doctor right immediately if you see any of them.

What are the Febuxostat 80mg Tablets Furic symptoms?

  • Hyperuricemia is a condition in which your blood contains too much uric
  • acid. High uric acid levels can cause a variety of disorders, including gout,
  • painful form of arthritis.
  • Gout
  • Joint discomfort is excruciating.
  • the rigidity of the joints
  • Affected joints are difficult to move.
  • Swelling and redness
  • of crooked joints For more click here.

Is febuxostat a life-threatening drug?

The most common cause of CV mortality in both groups was sudden cardiac death, which happened in 2.7 percent on febuxostat and 1.8 percent on allopurinol. Those on febuxostat had a greater risk of cardiovascular death during treatment or within 30 days after stopping it than those taking allopurinol.

If you are looking for another product or brand click here.